Endothelial microparticles as conveyors of information in atherosclerotic disease

Atherosclerosis

Volumn 234, Issue 2, 2014, Pages 295-302

  Schiro, A ^a,b   Wilkinson, F L ^c   Weston, R ^c   Smyth, J V ^a   Serracino Inglott, F ^a,b   Alexander, M Y ^b,c  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Carotid disease; Microparticles; Stroke

Indexed keywords

BIOLOGICAL MARKER; MITOGEN ACTIVATED PROTEIN KINASE P38; RHO KINASE; AUTACOID;

ANGIOCARDIOGRAPHY; APOPTOSIS; ARTERY EMBOLISM; ATHEROSCLEROTIC PLAQUE; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERIOGRAPHY; CAROTID ARTERY OBSTRUCTION; CELL ACTIVATION; CELL COMPOSITION; CELL MEMBRANE; CELL STRUCTURE; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; CYTOMETRY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; ECHOGRAPHY; ENDOTHELIAL MICROPARTICLE; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; HEART PROTECTION; HUMAN; IN VITRO STUDY; INFLAMMATION; LIPID OXIDATION; LIPOLYSIS; NONHUMAN; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEOMICS; PULMONARY HYPERTENSION; REVIEW; SHEAR STRESS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; ANIMAL; ATHEROSCLEROSIS; ENDOTHELIUM CELL; MEMBRANE MICROPARTICLE; METABOLISM; PATHOLOGY; PROGNOSIS;

ANIMALS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CELL-DERIVED MICROPARTICLES; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; PROGNOSIS; SIGNAL TRANSDUCTION;

EID: 84900848462     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.03.019     Document Type: Review

References (91)

1. VanWijk M.J., VanBavel E., Sturk A., et al. Microparticles in cardiovascular diseases. Cardiovasc Res 2003, 59:277-287.
2. Pasterkamp G., de Kleijn D. Microparticles, debris that hurts. JAm Coll Cardiol 2008, 52:1312-1313.
3. Sarlon-Bartoli G., Bennis Y., Lacroix R., et al. Plasmatic level of leukocyte-derived microparticles is associated with unstable plaque in asymptomatic patients with high-grade carotid stenosis. JAm Coll Cardiol 2013, 62(16):1436-1441.
4. Loyer X., Vion A.C., Tedgui A., et al. Microvesicles as cell-cell messengers in cardiovascular diseases. Circ Res 2014, 114:345-353.
5. Zwaal R.F., Comfurius P., Bevers E.M. Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci CMLS 2005, 62:971-988.
6. Tan X., Shi J., Fu Y., et al. Role of erythrocytes and platelets in the hypercoagulable status in polycythemia vera through phosphatidylserine exposure and microparticle generation. Thromb Haemost 2013, 109:1025-1032.
7. Comfurius P., Senden J.M., Tilly R.H., et al. Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. Biochim Biophys Acta 1990, 1026:153-160.
8. Coleman M.L., Sahai E.A., Yeo M., et al. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat Cell Biol 2001, 3:339-345.
9. Vion A.C., Ramkhelawon B., Loyer X., et al. Shear stress regulates endothelial microparticle release. Circ Res 2013, 112:1323-1333.
10. Burger D., Montezano A.C., Nishigaki N., et al. Endothelial microparticle formation by angiotensin II is mediated via Ang II receptor type I/NADPH oxidase/Rho kinase pathways targeted to lipid rafts. Arterioscler Thromb Vasc Biol 2011, 31:1898-1907.
11. Leroyer A.S., Rautou P.E., Silvestre J.S., et al. CD40 ligand+ microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization. JAm Coll Cardiol 2008, 52:1302-1311.
12. Sapet C., Simoncini S., Loriod B., et al. Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2. Blood 2006, 108:1868-1876.
13. Liu M.L., Williams K.J. Microvesicles: potential markers and mediators of endothelial dysfunction. Curr Opin Endocrinol Diabetes Obes 2012, 19:121-127.
14. Jimenez J.J., Jy W., Mauro L.M., et al. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 2003, 109:175-180.
15. Miguet L., Pacaud K., Felden C., et al. Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization. Proteomics 2006, 6:153-171.
16. Finn N.A., Eapen D., Manocha P., et al. Coronary heart disease alters intercellular communication by modifying microparticle-mediated microRNA transport. FEBS Lett 2013, 587(21):3456-3463.
17. Deregibus M.C., Cantaluppi V., Calogero R., et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 2007, 110:2440-2448.
18. Jansen F., Yang X., Hoelscher M., et al. Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles. Circulation 2013, 128(18):2026-2038.
19. Rautou P.E., Leroyer A.S., Ramkhelawon B., et al. Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migration. Circ Res 2011, 108:335-343.
20. Laffont B., Corduan A., Plé H., et al. Activated platelets can deliver mRNA regulatory Ago2•microRNA complexes to endothelial cells via microparticles. Blood 2013, 122:253-261.
21. Norling L.V., Dalli J. Microparticles are novel effectors of immunity. Curr Opin Pharmacol 2013, 13:570-575.
22. McCoy J.P. Basic principles of flow cytometry. Hematol/Oncol Clinics North Am 2002, 16:229-243.
23. Parker B., Al-Husain A., Pemberton P., et al. Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus. Ann Rheum Dis 2013, 10.1136/annrheumdis-2012-203028.
24. Heathfield S.K., Parker B., Zeef L.A., et al. Certolizumab pegol attenuates the pro-inflammatory state in endothelial cells in a manner that is atheroprotective. Clin Exp Rheumatol 2013, 31:225-233.
25. Dignat-George F., Boulanger C.M. The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol 2011, 31:27-33.
26. Gimbrone M.A. Vascular endothelium, hemodynamic forces, and atherogenesis. Am J Pathol 1999, 155:1-5.
27. Lusis A.J. Atherosclerosis. Nature 2000, 407:233-241.
28. Goldstein J.L., Ho Y.K., Basu S.K., et al. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A 1979, 76:333-337.
29. O'Brien K.D., McDonald T.O., Chait A., et al. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 1996, 93:672-682.
30. Libby P., Ridker P.M., Hansson G.K., et al. Inflammation in atherosclerosis: from pathophysiology to practice. JAm Coll Cardiol 2009, 54:2129-2138.
31. Tedgui A., Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006, 86:515-581.
32. Sakakura K., Nakano M., Otsuka F., et al. Pathophysiology of atherosclerosis plaque progression. Heart Lung Circ 2013, 22:399-411.
33. Doran A.C., Meller N., McNamara C.A. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 2008, 28:812-819.
34. Raines E.W., Ferri N. Thematic review series: the immune system and atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease. JLipid Res 2005, 46:1081-1092.
35. Aikawa E., Nahrendorf M., Sosnovik D., et al. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation 2007, 115:377-386.
36. Virmani R., Kolodgie F.D., Burke A.P., et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005, 25:2054-2061.
37. Moreno P.R., Purushothaman K.R., Zias E., et al. Neovascularization in human atherosclerosis. Curr Mol Med 2006, 6:457-477.
38. Virmani R., Kolodgie F.D., Burke A.P., et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000, 20:1262-1275.
39. Kaartinen M., Penttila A., Kovanen P.T. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation 1994, 90:1669-1678.
40. Yayan J. Emerging families of biomarkers for coronary artery disease: inflammatory mediators. Vasc Health Risk Manag 2013, 9:435-456.
41. Zhou Y., Ni Z., Zhang J., et al. Plasma pentraxin 3 may be a better marker of peripheral artery disease in hemodialysis patients than C-reactive protein. Vasc Med 2013, 18:85-91.
42. Nozaki T., Sugiyama S., Koga H., et al. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. JAm Coll Cardiol 2009, 54:601-608.
43. Cines D.B., Pollak E.S., Buck C.A., et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998, 91:3527-3561.
44. Nielsen C.T., Østergaard O., Johnsen C., et al. Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus. Arthritis Rheum 2011, 63:3067-3077.
45. Crookston K.P., Sibbitt W.L., Chandler W.L., et al. Circulating microparticles inneuropsychiatric systemic lupus erythematosus. Int J Rheum Dis 2013, 16:72-80.
46. Bernal-Mizrachi L., Jy W., Fierro C., et al. Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes. Int J Cardiol 2004, 97:439-446.
47. Werner N., Wassmann S., Ahlers P., et al. Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2006, 26:112-116.
48. Sinning J.M., Losch J., Walenta K., et al. Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes. Eur Heart J 2011, 32:2034-2041.
49. Simak J., Gelderman M.P., Yu H., et al. Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome. JThromb Haemost JTH 2006, 4:1296-1302.
50. Williams J.B., Jauch E.C., Lindsell C.J., et al. Endothelial microparticle levels are similar in acute ischemic stroke and stroke mimics due to activation and notapoptosis/necrosis. Acad Emerg Med Off J Soc Acad Emerg Med 2007, 14:685-690.
51. Simak J., Gelderman M.P. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 2006, 20:1-26.
52. Martinez M.C., Tual-Chalot S., Leonetti D., et al. Microparticles: targets and tools in cardiovascular disease. Trends Pharmacol Sci 2011, 32:659-665.
53. Suades R., Padro T., Alonso R., et al. Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells. Thromb Haemost 2013, 110:366-377.
54. Nomura S., Shouzu A., Omoto S., et al. Effects of losartan and simvastatin on monocyte-derived microparticles in hypertensive patients with and without type 2 diabetes mellitus. Clin Appl Thromb Hemost 2004, 10:133-141.
55. Mobarrez F., He S., Bröijersen A., et al. Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease. Thromb Haemost 2011, 106:344-352.
56. Labiós M., Martínez M., Gabriel F., et al. Effect of eprosartan on cytoplasmic free calcium mobilization, platelet activation, and microparticle formation in hypertension. Am J Hypertens 2004, 17:757-763.
57. Bulut D., Becker V., Mügge A. Acetylsalicylate reduces endothelial and platelet-derived microparticles in patients with coronary artery disease. Can J Physiol Pharmacol 2011, 89:239-244.
58. França C.N., Pinheiro L.F., Izar M.C., et al. Endothelial progenitor cell mobilization and platelet microparticle release are influenced by clopidogrel plasma levels in stable coronary artery disease. Circ J 2012, 76:729-736.
59. Chirinos J.A., Castrellon A., Zambrano J.P., et al. Digoxin use is associated with increased platelet and endothelial cell activation in patients with nonvalvular atrial fibrillation. Heart Rhythm 2005, 2:525-529.
60. Suades R., Padro T., Vilahur G., et al. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques. Thromb Haemost 2012, 108:1208-1219.
61. Navasiolava N.M., Dignat-George F., Sabatier F., et al. Enforced physical inactivity increases endothelial microparticle levels in healthy volunteers. Am J Physiol Heart Circ Physiol 2010, 299:H248-H256.
62. Gordon C., Gudi K., Krause A., et al. Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers. Am J Respir Crit Care Med 2011, 184:224-232.
63. Lacroix R., Judicone C., Mooberry M., et al. Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. JThromb Haemost 2013, 10.1111/jth.12207.
64. Brodsky S.V., Zhang F., Nasjletti A., et al. Endothelium-derived microparticles impair endothelial function invitro. Am J Physiol Heart Circ Physiol 2004, 286:H1910-H1915.
65. Densmore J.C., Signorino P.R., Ou J., et al. Endothelium-derived microparticles induce endothelial dysfunction and acute lung injury. Shock 2006, 26:464-471.
66. Mallat Z., Hugel B., Ohan J., et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 1999, 99:348-353.
67. Canault M., Leroyer A.S., Peiretti F., et al. Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1. Am J Pathol 2007, 171:1713-1723.
68. Leroyer A.S., Isobe H., Leseche G., et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. JAm Coll Cardiol 2007, 49:772-777.
69. Pei G., Powers D.D., Lentz B.R. Specific contribution of different phospholipid surfaces to the activation of prothrombin by the fully assembled prothrombinase. JBiol Chem 1993, 268:3226-3233.
70. Owens A.P., Mackman N. Microparticles in hemostasis and thrombosis. Circ Res 2011, 108:1284-1297.
71. Wilcox J.N., Smith K.M., Schwartz S.M., et al. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A 1989, 86:2839-2843.
72. Fourcade O., Simon M.F., Viode C., et al. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 1995, 80:919-927.
73. Pamuklar Z., Lee J.S., Cheng H.Y., et al. Individual heterogeneity in platelet response to lysophosphatidic acid: evidence for a novel inhibitory pathway. Arterioscler Thromb Vasc Biol 2008, 28:555-561.
74. Bot M., Bot I., Lopez-Vales R., et al. Atherosclerotic lesion progression changes lysophosphatidic acid homeostasis to favor its accumulation. Am J Pathol 2010, 176:3073-3084.
75. Davies M.J. Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. Circulation 1996, 94:2013-2020.
76. Rautou P.E., Vion A.C., Amabile N., et al. Microparticles, vascular function, and atherothrombosis. Circ Res 2011, 109:593-606.
77. Distler J.H., Jüngel A., Huber L.C., et al. The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. Proc Natl Acad Sci U S A 2005, 102:2892-2897.
78. Dashevsky O., Varon D., Brill A. Platelet-derived microparticles promote invasiveness of prostate cancer cells via upregulation of MMP-2 production. JInt Cancer 2009, 124:1773-1777.
79. Mesri M., Altieri D.C. Endothelial cell activation by leukocyte microparticles. JImmunol 1998, 161:4382-4387.
80. Scanu A., Molnarfi N., Brandt K.J., et al. Stimulated T cells generate microparticles, which mimic cellular contact activation of human monocytes: differential regulation of pro- and anti-inflammatory cytokine production by high-density lipoproteins. JLeukoc Biol 2008, 83:921-927.
81. Barry O.P., Pratico D., Savani R.C., et al. Modulation of monocyte-endothelial cell interactions by platelet microparticles. JClin Invest 1998, 102:136-144.
82. Perez-Casal M., Downey C., Cutillas-Moreno B., et al. Microparticle-associated endothelial protein C receptor and the induction of cytoprotective and anti-inflammatory effects. Haematologica 2009, 94:387-394.
83. Abid Hussein M.N., Boing A.N., Sturk A., et al. Inhibition of microparticle release triggers endothelial cell apoptosis and detachment. Thromb Haemost 2007, 98:1096-1107.
84. Gasser O., Schifferli J.A. Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis. Blood 2004, 104:2543-2548.
85. Huynh M.L., Fadok V.A., Henson P.M. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. JClin Invest 2002, 109:41-50.
86. Fadok V.A., Bratton D.L., Konowal A., et al. Macrophages that have ingested apoptotic cells invitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. JClin Invest 1998, 101:890-898.
87. Zernecke A., Bidzhekov K., Noels H., et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009, 2:ra81.
88. Benameur T., Tual-Chalot S., Andriantsitohaina R., et al. PPARalpha is essential for microparticle-induced differentiation of mouse bone marrow-derived endothelial progenitor cells and angiogenesis. PloS One 2010, 5:e12392.
89. Mause S.F., Ritzel E., Liehn E.A., et al. Platelet microparticles enhance the vasoregenerative potential of angiogenic early outgrowth cells after vascular injury. Circulation 2010, 122:495-506.
90. Venable A.S., Williams R.R., Haviland D.L., et al. An analysis of endothelial microparticles as a function of cell surface antibodies and centrifugation techniques. JImmunol Methods 2014 Mar 4, pii: S0022-1759(14)00069-6. 10.1016/j.jim.2014.02.010.
91. Nomura S., Kanazawa S., Fukuhara S. Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus. JHum Hypertens 2002, 16:539-547.